Discovering, developing and advancing diagnosis, new medicines and treatments for patients

The Leicester Precision Medicine Institute (LPMI) brings together the research expertise and facilities of the University of Leicester and University Hospitals Leicester NHS Trust with industry to advance new medicines and medical technology innovations to impact on healthcare in our multi-ethnic population.

 Integration of new technologies is providing much more information about health and disease that we are using to better predict, diagnose and treat disease. Through LPMI partners we are ensuring more rapid delivery of improved healthcare to our patients in the UHL NHS trust, the wider UK and the world.

What is precision medicine?

What is precision medicine

We will be adding to our website over the next few weeks, please come back to visit us. If you have any enquires please contact us at

LPMI About Us  Leicester Precision Medicine Institute Team



Share this page:


New clues about why non-smokers, as well as smokers, develop chronic lung disease revealed Read more here

University of Leicester receives share of £34m BHF investment to help safeguard UK’s world-class research status Read more here

Professor Jacqui Shaw talks to the Guardian. Could we soon be able to detect cancer in 10 minutes? Read more here

Innovative healthcare project to link patient data receives government funding Read more here

Call for abstracts in the areas of Cancer, Diabetes, Respiratory Sciences - Midlands AMS Research Festival 2019 Read more here

View photographs of the LPMI PhD Student Welcome Day 2018 event here

Congratulations to Professor Jacqui Shaw, LPMI Director is one of BioBeat’s 50 Movers and Shakers for 2018. Read more here

View slides from the LPMI August 18 Exec meeting. Read more here

Improving diagnosis of the causes of heart failure. Read more here  

LPMI committee member, Professor Gerry McCann is awarded prestigious research professorship Read more here

The newly published Allocations Booklet sets out how all government science, research and innovation budgets have been allocated until March 2021 Read more here

The Midlands Innovation Commercialisation of Research Accelerator (MICRA) project is establishing the UK's largest, formal technology transfer office collaboration   Read More

Article about detecting cancer from a 'liquid biopsy'. Read more here

More LPMI News Here


For LPMI Enquiries:

Professor Jacqui Shaw

Dr Ruth Barber

Dr Carl Edwards

Dr Riddhi Shukla


t: +44 (0)116 223 1594



LD3 logo

LD3 Office:

+44 (0)116 252 3342